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1  | INTRODUC TION
Already in 1966, intermittent catheterization was recognized as the 
preferred method for early bladder management of the spinal in‐
jured patient (Guttmann & Frankel, 1966). Since then, the technique 
(Lamin & Newman, 2016; Lapides, Diokno, Silber, & Lowe, 1972) 
and catheters have been developed to optimize user‐friendliness 
and to reduce the risk of complications such as urinary tract infec‐
tions (UTI) and urethral trauma. Today, intermittent catheterization 
is the preferred first therapy choice in favour of indwelling cathe‐
terization (Hooton et al., 2010; Lamin & Newman, 2016; Tenke et 
al., 2008; Tenke, Koves, & Johansen, 2014). Most national and in‐
ternational guidelines, such as the European Association of Urology 
(EAU) Guideline on Neuro‐Urology and the European Association 
of Urology Nurses (EAUN), recommend intermittent catheteriza‐
tion as the standard treatment for patients who are unable to empty 
their bladder (Blok et al., 2015; Vahr et al., 2013). A well‐educated 
nurse specialist is often responsible for teaching intermittent cath‐
eterization (Vahr et al., 2013) and a clean (Lapides et al., 1972; Vahr 
et al., 2013) or aseptic technique is usually recommended (Blok et 
al., 2015; Vahr et al., 2013). This, together with good patient ed‐
ucation, good patient adherence, and proper catheter material, is 
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Abstract
Aims: This study investigated user perception and adherence related to a hydro‐
philic‐coated urinary catheter (LoFric® Origo™), available for male patients who 
practice intermittent catheterization.
Design: The study had a prospective observational design, including patients from 19 
European hospitals.
Methods: A total of 416 patients were eligible for the study; 179 experienced cath‐
eter users and 237 de novo. Two questionnaires were filled out, one describing back‐
ground data and a second, 8 weeks later, evaluating catheter features.
Results: The response rate for the second questionnaire was 88% (365 patients). 
Patients evaluating the new catheter showed a general satisfaction rate of 81% and 
72% kept using it. The hygienic grip of the catheter was appreciated by 85% and the 
foldable feature by 67%. The results show that convenience, ease of use, and hy‐
gienic factors are patient‐preferred features for a urinary catheter. These factors 
were confirmed for the evaluated hydrophilic‐coated catheter.
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an essential part of making the therapy as safe and effective as in‐
tended (Vahr et al., 2013; Wyndaele, 2002, 2002 ).
There are many reported barriers associated with intermittent 
catheterization that can potentially reduce the positive outcomes of 
the therapy. As a result, there is a strong research focus on supportive 
healthcare professionals that can promote the therapy and specific 
catheters adapted to patients’ individual needs. The purpose of the 
current study is to investigate patients’ perception of and adherence 
to a newly developed hydrophilic‐coated catheter (LoFric® Origo™, 
Wellspect HealthCare, DENTSPLY IH AB, Sweden). A greater under‐
standing of patients’ preferences, needs, and opinions is essential to 
ensure good adherence and outcome of intermittent catheterization.
2  | BACKGROUND
Patient compliance or, more properly: “patient adherence”, is a key 
factor for ensuring a good clinical outcome (Vermeire, Hearnshaw, 
van Royen, & Denekens, 2001). Nonadherence has been identified as 
a major public health problem and it is associated with a significant fi‐
nancial burden (Vermeire et al., 2001). Several factors seem to affect 
adherence and two general examples are (a) shared decision‐making be‐
tween a healthcare professional and patient (Vermeire et al., 2001); and 
(b) fitting the treatment solution into the patient’s everyday life (Gold & 
McClung, 2006; Morris & Schulz, 1993). For intermittent catheteriza‐
tion, it is known that poor adherence to the therapy can cause urinary 
and renal complications (Vahr et al., 2013; van Achterberg, Holleman, 
Cobussen‐Boekhorst, Arts, & Heesakkers, 2008). The critical factors for 
adherence or how common it is, are still unknown (van Achterberg et al., 
2008). One contributing factor to good adherence seems to be ensur‐
ing that patients are given an individualized catheter choice (Bardsley, 
2016; Bermingham et al., 2013; Chick, Hunter, & Moore, 2013; Hill et 
al., 2013; Kelly, Spencer, & Barrett, 2014; NICE, 2012; Wilde, Brasch, 
& Zhang, 2011; Woodward, 2013). For this reason, understanding pa‐
tients’ preferences, needs, and opinions about specific catheters and 
catheter features is essential if the consequences of nonadherence are 
to be avoided. There are a few reports available describing appreciated 
attributes for catheters by patients. Risk reduction of UTI, ease of in‐
sertion, and convenience (Neovius & Lundqvist, 2014; Pinder, Lloyd, 
Nafees, Elkin, & Marley, 2015) seem to be important features, but these 
findings still need to be translated into practical terms for specific cath‐
eters. Addressing barriers is another important factor in obtaining good 
adherence (van Achterberg et al., 2008). Many barriers to practicing in‐
termittent catheterization exist. Some of the most commonly reported 
include:
• Inconvenience related to preparations (Cobussen‐Boekhorst, 
Hermeling, Heesakkers, & van Gaal, 2016)
• Access to bathrooms (Bolinger & Engberg, 2013; Seth, Haslam, & 
Panicker, 2014; Wilde et al., 2011)
• Age (Cobussen‐Boekhorst, Beekman, et al., 2016)
• Overall knowledge, fears, and understanding of the concept (van 
Achterberg et al., 2008).
Some of these barriers can be addressed by healthcare profes‐
sionals and their communication skills and attitudes are instrumental 
in promoting confidence for patients and enabling long‐term adher‐
ence to the therapy (Vahr et al., 2013). Some of the barriers can be 
addressed by catheter choice and imply that a convenient catheter 
may improve adherence (Bennett, 2002). Awareness and knowledge 
among healthcare professionals is, however, key to implementing 
the use of intermittent catheterization by specific catheters in the 
everyday situation (Cobussen‐Boekhorst, Beekman, et al., 2016; 
Cobussen‐Boekhorst, Hermeling, et al., 2016; van Achterberg et al., 
2008).
Specific catheter types for intermittent use are debated. A re‐
cent Cochrane review concluded that solid evidence for the superi‐
ority of a specific catheter or technique is lacking and that catheter 
choice will be dependent on personal preference, cost, portabil‐
ity, and ease of use (Prieto, Murphy, Moore, & Fader, 2014, 2015). 
Previous work has shown that catheter features and preferences 
can improve patients’ quality of life related to intermittent cath‐
eterization (Chartier‐Kastler et al., 2013) and that is why the cur‐
rent study focuses on assessing user perception and adherence. 
The current catheter investigated is a hydrophilic‐coated catheter. 
Hydrophilic catheters were developed in the early 1980s to prevent 
long‐term complications associated with repeated catheterizations 
with uncoated catheters (Perrouin‐Verbe et al., 1995; Wyndaele & 
Maes, 1990). Hydrophilic catheters are known to be easy to use and 
comfortable (Chartier‐Kastler & Denys, 2011; Seth et al., 2014) but 
specific catheter features described by patients are lacking. Many 
patients prefer hydrophilic catheters when they have the choice 
(Chartier‐Kastler & Denys, 2011). Hydrophilic catheters have been 
reported to prevent urethral trauma (Chartier‐Kastler & Denys, 
2011; Hedlund, Hjelmas, Jonsson, Klarskov, & Talja, 2001; Li, Ye, 
Ruan, Yang, & Zhang, 2013; Vahr et al., 2013) and reduce the risk of 
UTIs (Cardenas & Hoffman, 2009; Cardenas et al., 2011; Chartier‐
Kastler & Denys, 2011; De Ridder et al., 2005; Li et al., 2013; Tenke 
et al., 2014; Vapnek, Maynard, & Kim, 2003; Woodbury, Hayes, & 
Askes, 2008), also after long‐term use (Bakke, Digranes, & Hoisaeter, 
1997; Hakansson, Neovius, Norrback, Svensson, & Lundqvist, 2015; 
Waller, Jonsson, Norlen, & Sullivan, 1995). As a result, hydrophilic‐
coated catheters have been identified as a cost‐effective contribu‐
tor in UTI prevention, although it is recognized that catheter choice 
should not solely be based on UTI risk as patient comfort and ease of 
use are important criteria (Lamin & Newman, 2016).
3  | THE STUDY
3.1 | Design
This was a prospective study, observing real‐life use of intermittent 
catheterization in a cohort of male patients. The inclusion criteria 
were male patients, 18 years and older, who practiced daily intermit‐
tent catheterization with LoFric Origo, a hydrophilic‐coated cathe‐
ter. LoFric Origo is a male, ready‐to‐use catheter that is foldable into 
pocket size and has an adjustable insertion grip to enable no‐touch 
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catheterization. The packaging has a discrete design and doubles as 
a hygienic disposal pouch.
3.2 | Method
Patients attending or newly admitted at any of the 19 participating 
European clinics/hospitals (two in Switzerland, three in Belgium, 
two in the Netherlands, four in Norway, four in France, and four in 
the UK) were asked to participate in the study. Included patients 
were asked to fill out two questionnaires. The selection of ques‐
tions in the patient‐reported questionnaires were based on pre‐
vious findings from studies of similar catheters (e.g., (Johansson 
et al., 2013)), experiences from product development from the 
manufacturer and clinical expertise. That is, during questionnaire 
development, content validity was considered by clinical experts 
part of the LoFric Origo study group. The views and opinions of 
urology nurses, urotherapists, continence advisors, urologists, 
and neuro‐urologists were considered. Internal validity and re‐
liability of the questionnaires were not formally tested but the 
design reflected consistency with previous experiences from 
clinical studies and product development. The first questionnaire 
collected background data (e.g., reason for therapy, hand func‐
tion, urethral sensitivity) and was filled out when attending the 
clinic. Specific data (e.g., catheter type, time on catheter, cathe‐
terization frequency, and perception of handling, satisfaction and 
convenience) were collected for patients with previous experi‐
ence with intermittent catheterization. This was not applicable 
for newly admitted patients. The second questionnaire collected 
data on patient preferences and specific catheter features (e.g., 
perception of handling, satisfaction, convenience) and captured if 
the patients still used the catheter or any reasons for discontinu‐
ation (i.e., adherence). The second questionnaire also contained 
a list of 19 commonly reported catheter attributes (e.g., easy to 
open, discrete design, ready to use) and patients were asked to 
identify and list three features that best/least described the eval‐
uated catheter. The list was identified based on clinical expertise 
and current findings about important catheter attributes and bar‐
riers to intermittent catheterization (described in the background 
section). The second questionnaire was filled out in the patients’ 
home‐setting 8 weeks after the first questionnaire and clinical 
visit. Full questionnaires and the specific questions are found in 
supplementary material. Data were collected between February 
2013 and March 2015.
3.3 | Analysis
Descriptive statistics were used to analyse epidemiological data, 
that is, number of patients (N), mean, standard deviation (SD) for 
continuous data, and frequencies and percentages for categori‐
cal data. Primary analyses were conducted on the complete data 
from all countries. Missing data were not replaced or estimated, 
resulting in percentages based on the actual numbers and vary‐
ing total N. Ordinal categorical data based on a 5‐grade scale with 
one neutral and two positive/negative answers were transformed 
into a three‐grade scale (i.e., positive, neutral, negative) when pre‐
sented. For example, patients who answered either “completely 
satisfied” or “satisfied” were combined to describe “satisfaction”. 
Patients who answered either “not satisfied” or “not satisfied at 
all” were combined to describe “not satisfied”. All categories were 
considered and used in statistical testing. The descriptive and 
noninterventional nature of the research limits the use of a formal 
sample size estimation and inclusion was made in an arbitrary man‐
ner with the goal of covering a sample between 160‐600 patients. 
Statistical tests, using nonparametric tests and with p‐values below 
0.05 considered as statistically significant, were performed when 
appropriate. This included the Wilcoxon rank sum test for exploring 
differences between unrelated subgroups (i.e., adherent vs. nonad‐
herent patients or new vs. experienced users) and the McNemar 
test to compare the results between paired observations (i.e., 
previous catheter experience vs. hydrophilic‐coated catheter). All 
analyses were exploratory and hypothesis generating for further 
research.
3.4 | Ethics
The study was registered at clinicaltrials.gov with the identifier 
NCT01796587 and reviewed and/or approved by applicable ethics 
committees. That is:
• Commissie Medische Ethiek Van Se Universitaire ZiekenHuizen 
Kuleuven — Leuven, Belgium (Belgisch Nummer B322201318122)
• Commission cantonale valasanne d’ethique médicale — Sion, 
Switzerland (CCVEM 011/13)
• Ethikkommission des Kantons Luzern — Luzern, Switzerland 
(Ref. Nr. EK:13,048), Commissie Mensgebonden Onderzoek — 
Nijmegen, the Netherlands (Registratienummer: 2012/504)
• Toetsingscommissie Patiëntgebonden onderzoek — Gorinchem, 
the Netherlands (CH/ds/13–249)
• Regionale komiteer for medisinsk og helsefaglig forskningsetikk 
(REK sør‐øst) — Oslo, Norway (Ref: 2013/187)
• NRES Committee London, City & East — Bristol, UK (No approval 
required)
• Commission Nationale de I’Infomatique et des Libertés 
(CNiL) — Paris, France (N/Réf.: EGY/VCS/AR132977, Décision 
DR‐2013–135)
• Comité consultative sur le traitement de l’informatyion en matiére 
de recherché dans le domaine de la santé (CCTRIS)/Ministére De 
l’Enseignement Supérieur Et De La Recherche – Paris, France 
(DGRI CCTRIS MG/CPᵒ13.053/Dossier no 13.080).
Every patient had given informed consent before participation. 
The catheter choice and prescription was made before the deci‐
sion to participate in the study and no free catheter samples were 
provided in addition to those which were part of standard care. 
Payment and reimbursement for catheters followed standard rou‐
tines of the country.
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4  | RESULTS
A total of 423 patients agreed to participate in the study but 
background data were only available for 416 patients (Table 1 
and Figure 1). That is, seven patients were either wrongfully 
included or withdrew their consent, leaving 416 patients with 
demography data. Of the 416 patients, 179 had previous ex‐
perience with catheter use and intermittent catheterization 
(Table 2 & Figure 1). A total of 365 patients returned the sec‐
ond questionnaire after 8 week’s use of the hydrophilic cath‐
eter, resulting in a response rate of 88% (Table 2 & Figure 1). 
Figure 1 summarizes the patient flow in the study. The studied 
population reflected a wide range of patients with the common 
need for daily intermittent catheterization. Background data are 
found in Table 1.
4.1 | Findings related to previous catheter
A total of 179 patients had previous experience with intermittent 
catheterization. Of those, 86 patients (48%) had previously used 
LoFric catheters (Wellspect HealthCare, DENTSPLY IH AB, Sweden), 
70 patients (39%) used SpeediCath/EasiCath catheters (Coloplast 
A/S, Denmark), and 23 patients (13%) used other brands (VaPro, 
Teleflex, Hydrosil, Actreen, and iQCath). Most patients used a 
Nelaton catheter tip (N = 156; 88%), Charrière size 12 or 14 (N = 162; 
91%), and 40 cm length (N = 159; 89%). A majority of users found 
their previous catheter easy to use and 79% (N = 141) were satisfied 
with it. It was noted that 32% (N = 57) touched the coated part of 
their previous catheter during catheterization and could potentially 
benefit from an insertion grip (Table 2).
4.2 | Findings related to the hydrophilic‐
coated catheter
A total of 365 patients returned the second questionnaire, a re‐
sponse rate of 88%. Of those individuals, 72% (N = 261) were 
still using the hydrophilic‐coated catheter. The remaining 28% 
(N = 104) had discontinued their use either instantaneously after 
less than 1 week (N = 16; 15%), after 1–2 weeks (N = 20; 19%), or 
after 3–7 weeks of use (N = 61; 59%). The reasons for discontinua‐
tion among the 28% who discontinued were no persistent need to 
catheterize (N = 24; 7%), a therapy switch (N = 6; 2%), a catheter 
switch (N = 69; 19%), or other reasons (N = 5; 1%). The reported 
reasons for catheter switch were due to preference (N = 46; 13%), 
a supply shortage at the pharmacy (N = 8; 2%), complications 
(N = 12; 3%), or advice from a healthcare professional (N = 3, 1%). 
Adequate training before starting with LoFric Origo was reported 
by 94% (N = 335/358) and 6% (N = 23/358) reported that this was 
lacking. See details in Table 2.
Patients evaluating the hydrophilic catheter showed a gen‐
eral satisfaction rate of 81% (N = 289/359). Satisfaction rate 
was also statistically associated with adherence. That is, among 
those still on the hydrophilic catheter, 99% (N = 257/260) re‐
ported satisfaction. This can be compared with those who aban‐
don the hydrophilic catheter, who reported a satisfaction of 64% 
(N = 63/90),  (p < 0.001 [Wilcoxon rank sum test]). New users, with 
previous experience (up to 3 months), were generally more sat‐
isfied (N = 202/223; 91%) with the hydrophilic‐coated catheter 
as compared with users with more than 3 months’ experience 
(N = 87/136; 64%; p < 0.001 [Wilcoxon rank sum test]). Most 
patients (N = 305/358; 85%) perceived the hydrophilic‐coated 
catheter as hygienic due to the insertion grip. The foldable fea‐
ture was deemed as important by 67% (N = 236/351) and 89% 
(N = 309/349) thought that the catheter had an appealing design. 
The result was that 85% (N = 298/351) would recommend the 
hydrophilic‐coated catheter to a friend and 77% (N = 271/354) 
would like to continue using it. When patients were asked to list 
the attributes best describing the hydrophilic‐coated catheter 
from a list of 19 features the following three were most common:
TA B L E  1   Background data
Background data 
NB: Only male patients included
Age (N = 418)
Mean (SD) 58 (16)
Median (Min‐Max) 63 (18–87)
Main reason for intermittent catheteriza‐
tion (N = 416)
N %
Brain and/or spinal cord disease (e.g., 
multiple sclerosis, myelitis, tumor, cyst)
55 13%
Neural tube defects (e.g., spina bifida) 9 2%
Spinal cord injury, paraplegia 61 15%
Spinal cord injury, tetraplegia 13 3%
Bladder dysfunction (e.g., underactive 
detrusor, overactive bladder)
113 27%
Bladder outlet obstruction (e.g., prostate 
hyperplasia)
117 28%
Postsurgical condition (e.g., neobladder, 
orthotopic bladder substitutes)
10 2%
Other (e.g., strictures) 38 9%
Time on intermittent catheterization (N = 416)
New user 237 57%
<3 months 22 5%
3 months–1 year 13 3%
1–3 years 40 10%
>3 years 104 25%
Hand function (N = 416)
Normal 369 89%
Slightly reduced 35 8%
Considerable reduced 12 3%
Urethral sensation (N = 416)
Normal 323 78%
Reduced 60 14%
No sensitivity 33 8%
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• Insertion aid—hygienic
• Ready to use
• Foldable—easy to carry
All features are listed in the questionnaires provided in supplemen‐
tary materials.
When comparing the results reported for the previous catheter 
to the hydrophilic‐coated catheter, similar values were reported for 
satisfaction (79% vs. 81%; p‐value = 0.5657 [McNemar test]), ease 
of use at insertion (78% vs. 83%; p‐value = 0.0886 [McNemar test]), 
and withdrawal (92% vs. 92%; p‐value = 0.3261 [McNemar test]). 
See details in Table 2.
5  | DISCUSSION
The results from this study show that real‐life use of the evalu‐
ated hydrophilic‐coated catheter seems to work well since the gen‐
eral perception by patients was positive and high satisfaction was 
reported. Patient satisfaction scores seem to be related to adher‐
ence as there was a statistically significant higher satisfaction (99%) 
among those still on the hydrophilic catheter compared with those 
who abandon the hydrophilic catheter (64% satisfaction). The gen‐
eral adherence in this study was 72% after 8 weeks. General adher‐
ence to intermittent catheterization has been reported to be about 
50% after 1 year (Cobussen‐Boekhorst, Beekman, et al., 2016), but 
this is very much dependent on the studied population. It is difficult 
to draw specific causality conclusions on satisfaction and adherence 
associated with specific features of the hydrophilic‐coated catheter. 
Patients, however, acknowledged the use of the insertion grip on 
the hydrophilic‐coated catheter and it was seen as a hygienic meas‐
ure, enabling nontouch catheterization. Furthermore, a total of 81% 
found the hydrophilic‐coated catheter easy to use.
When comparing the results reported from patients with previous 
catheter experience to the results reported from everyone who eval‐
uated the hydrophilic‐coated catheter, similar values were reported 
related to satisfaction, ease of use at insertion, and withdrawal. When 
considering these results it should be noted that the group evaluating 
the hydrophilic‐coated catheter also comprised new users, in contrast 
to the group of previous catheter users. New users may still be in the 
process of accepting their illness and learning to practice intermittent 
catheterization (Nevedal, Kratz, & Tate, 2016; Shaw & Logan, 2013). 
These factors could potentially affect the results in favour of users 
with previous catheter experience. However, new users were found 
to be generally more satisfied with the hydrophilic‐coated catheter, 
as compared with experienced users and this suggests that habit and 
experience as such are more important factors determining general 
perception. The results imply that experienced users are less willing 
to change catheters and, if there are no complications, prefer to stick 
to the catheter they first started with. It may also reflect that not a 
single catheter choice suits everybody and individual needs and pref‐
erences differ between catheter users. That is, the experienced users 
in this study may have other catheter preferences than the features 
provided by the hydrophilic‐coated catheter. Another possible expla‐
nation for switching catheters is selective insurance coverage since 
this sometimes restricts a patient’s preferred choice (e.g., the reim‐
bursement level may only cover low‐priced catheters).
The results related to the hydrophilic‐coated catheter confirm 
previous reports that describe general patient‐preferred catheter 
features and add more specific details on each general attribute. 
Portability of the catheter (i.e., easy to carry), hygiene, and read‐
iness for use were all reported as important features of the eval‐
uated hydrophilic‐coated catheter and this is in line with previous 
literature (Chartier‐Kastler et al., 2013; Neovius & Lundqvist, 
2014; Pinder et al., 2015), but it is also more specific. For exam‐
ple, Pinder et al. (Pinder et al., 2015) and Neovius and Lundqvist 
(Neovius & Lundqvist, 2014) highlight infection prevention as 
the most important general feature for catheters. In the cur‐
rent study, the hygienic insertion grip of the hydrophilic‐coated 
catheter was experienced as important by 85% of the users. 
Furthermore, Pinder et al. (Pinder et al., 2015) describe ease of 
insertion and convenience as important catheter features. Both of 
F I G U R E  1   Patient flow
N = 423
Informed consent
N = 416
Demography data
N = 7
Withdrawn 
consent/wrongfully 
included
N = 179
Experienced users, 
Returned quesonnaire 1
N = 237
New users
N = 365
Returned quesonnaire 2
N = 51
Drop-out, lost to follow up
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TA B L E  2   Catheter characteristics
Previous catheter 
(N = 179)
LoFric Origo 
(N = 365) p‐value
Time on previous catheter
<3 months 27 15% NA
3 months–1 year 22 12% NA
1–3 years 45 25% NA
>3 years 85 47% NA
Daily catheterization frequency
1 time per day 13 7% 48a 16%
2 times per day 16 9% 61a 20%
3 times per day 17 9% 32a 11%
4 times per day 24 13% 55a 18%
5 times per day 55 31% 61a 20%
6 times per day 35 20% 30a 10%
7 times per day 10 6% 7a 2%
>7 times per day 9 5% 8a 3%
Position during catheterization
Sitting 61 34% 86b 24%
Standing 111 62% 264b 74%
Lying down 7 4% 9b 3%
Patients satisfaction 0.5657k
Completely satisfied/
satisfied
141 79% 289b 81%
Neutral 29 16% 32b 9%
Not satisfied/not satisfied 
at all
9 5% 38b 11%
Handling at insertion 0.0886k
Very easy/easy 139 78% 300c 83%
Neutral 29 16% 42c 12%
Difficult/very difficult 11 6% 18c 5%
Touching coating during catheter insertion
Yes 57 32% NA
No, I use enclosed 
insertion aid
52 29% NA
No, I use separate 
insertion device
16 9% NA
No, I hold connector 54 30% NA
Insertion grip easy to use
Yes NA 291b 81%
No NA 29b 8%
Do not use NA 39b 11%
Handling at withdrawal 0.3261k
Very easy/easy 164 92% 332c 92%
Neutral 13 7% 21c 6%
Difficult/very difficult 2 1% 7c 2%
Disposal 1.0000k
Very easy/easy 123d 69% 281c 78%
(Continues)
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these are confirmed by patients in the current study and conve‐
nience in this study is translated into more specific features such 
as catheter’s easy portability and the fact that it is ready to use. 
Chartier‐Kastler et al., (2013) also conclude that a small catheter 
design increases quality of life among patients practicing intermit‐
tent catheterization. The results from the current study seem to 
verify this conclusion as 89% found the slim catheter design of the 
hydrophilic‐coated catheter appealing and 67% found the foldable 
feature of the catheter to be important.
5.1 | Limitations
Any observational study has its inherent limitations related to the 
design. For example, causality relationships are compromised by the 
fact that it is not possible to control factors having an impact on the 
outcome. Observational research is, however, a useful way to ob‐
serve real‐life situations and to understand current clinical practice. 
It should be noted that in the current study no financial incentives 
were influencing the patients’ preferences or opinions (i.e., no free 
catheter samples were given in addition to those which were part of 
normal routines) and that is why the results are considered to reflect 
“real world data” and normal routines associated with intermittent 
catheterization.
Another limitation of the study was the use of a nonvalidated 
patient‐reported questionnaire for collection of the study variables. 
The selected questions were, however, based on previous findings 
from studies (e.g., (Johansson et al., 2013)), experiences from prod‐
uct development, and clinical expertise. It is acknowledged that since 
the time point of the study, validated forms have been published that 
might have been suitable for this study. Full questionnaires can be 
reviewed in supplementary material.
As with any survey, the current study is compromised by some 
patients who are lost during follow‐up and data that are missing. 
The reasons for drop‐out are not known but the overall response 
rate (88%) is higher than other surveys of similar populations 
where 23% (Woodbury et al., 2008) and 56% (Hakansson et al., 
2015) are reported. Even though the overall response rate seems 
high, the completeness of each individual questionnaire was not 
ideal as patients felt that they were not able to answer all spe‐
cific questions. To limit biases, missing data were not computed 
or replaced and percentages presented were based on available 
answers only. Finally, it is acknowledged that the respondents 
were self‐selecting and it is impossible to say if they constitute a 
representative sample of the whole population applicable for in‐
termittent catheterization. However, the generous inclusion cri‐
teria and the substantial total number of patients provide a good 
basis for the generalizability of the results.
6  | CONCLUSIONS
Patients reported a high level of satisfaction and adherence to the 
evaluated hydrophilic‐coated catheter. Patients acknowledged 
the usefulness of the hygienic insertion grip of the hydrophilic‐
coated catheter, enabling nontouch catheterization. The results 
confirm previous reports that describe patient‐preferred catheter 
features to be convenience, ease of use, and infection prevention. 
It adds knowledge of preferred and appreciated specific catheter 
attributes such as portability and that a catheter can be folded, 
ready to use, and include hygienic measures such as an insertion 
grip.
Previous catheter 
(N = 179)
LoFric Origo 
(N = 365) p‐value
Neutral 33d 19% 53c 15%
Difficult/very difficult 22d 12% 26c 7%
Practical at home 150 86% 281e 82% 0.4705k
Practical out of home 111 64% 231e 66% 1.0000k
Additional bladder management
Spontaneously voiding 56 31% 162f 47%
External compression 7 4% 5f 1%
Other (e.g., indwelling 
catheter, pads)
7 4% 10f 3%
Incontinence between 
catheterizations
67g 37% 76h 21%
Self‐catheterization 174i 98% 347j 98%
Note. NA = Not applicable.
aN = 302. bN = 359. cN = 360. dN = 178. eNot all patients were able to answer this question. That is, N = 174 (home setting), N = 173 (out of home) for 
previous catheter and N = 342 (home setting) and N = 350 (out of home) for LoFric Origo. fN = 343. gAmong those who experienced incontinence, 61% 
(N = 41) emptied their bladder five to seven times daily, 16% (N = 11) three to four times daily and 22% (N = 15) one to two times daily. hAmong those 
who experienced incontinence, 42% (N = 27) emptied their bladder five to seven times daily, 19% (N = 12) three to four times daily and 39% (N = 25) 
one to two times daily. iN = 178. jN = 354. kMcNemar test considering patients with paired observations only. 
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6.1 | Implications for clinical practice
To ensure good adherence of intermittent catheterization, it is im‐
portant to ensure that patients are given a choice of a convenient 
and easy to use catheter that minimizes any risk of infection. Good 
adherence is believed to reduce the risk of complications and to opti‐
mize the outcome of the therapy. The results from the current study 
propose that the hydrophilic‐coated catheter, LoFric Origo, fulfils 
patient‐preferred catheter requirements and for this reason it seems 
to be a useful addition to nurses’ arsenal of catheters offered to 
men who are introduced to intermittent catheterization. In addition, 
it may be a useful alternative for experienced users of intermittent 
catheterization who are not satisfied with their current treatment.
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